ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Social Stream
ProQR Therapeutics NV (PRQR) Price Targets From Analysts
Use the tables below to see what analysts covering ProQR Therapeutics NV think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $33 | $18 | $22.75 | $8.04 | 182.96% |
The Trend in the Analyst Price Target
PRQR's average price target has moved up $3.43 over the prior 12 months.
Over the past 18 months, PRQR's average upside potential has been 306.83%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-07 | 4 | 33.00000 | 18.00000 | 22.75000 | 8.41 | 170.51% |
| 2021-07-02 | 7 | 39.57211 | 17.80745 | 25.34514 | 6.51 | 289.33% |
| 2021-07-02 | 7 | 39.60979 | 17.82441 | 25.36927 | 6.51 | 289.7% |
| 2021-07-02 | 7 | 39.37001 | 17.71650 | 25.21569 | 6.51 | 287.34% |
| 2021-07-02 | 7 | 39.25528 | 17.66488 | 25.14222 | 6.51 | 286.21% |
| 2021-07-02 | 7 | 39.58011 | 17.81105 | 25.35026 | 6.51 | 289.4% |
| 2021-07-02 | 7 | 39.46739 | 17.76033 | 25.27806 | 6.51 | 288.3% |
| 2021-07-02 | 7 | 39.22160 | 17.64972 | 25.12064 | 6.51 | 285.88% |
| 2021-07-02 | 7 | 39.33632 | 17.70135 | 25.19412 | 6.51 | 287.01% |
| 2021-04-15 | 6 | 45.15092 | 18.47088 | 26.67529 | 6.18 | 331.64% |
| 2021-04-15 | 7 | 45.15092 | 18.47088 | 26.67529 | 6.18 | 331.64% |
| 2021-04-15 | 6 | 45.02007 | 18.41735 | 26.59799 | 6.18 | 330.39% |
| 2021-04-15 | 7 | 45.02007 | 18.41735 | 26.59799 | 6.18 | 330.39% |
| 2021-04-15 | 6 | 44.41549 | 18.17002 | 26.24080 | 6.18 | 324.61% |
| 2021-04-15 | 7 | 44.41549 | 18.17002 | 26.24080 | 6.18 | 324.61% |
| 2021-04-15 | 6 | 44.84288 | 18.34486 | 26.49331 | 6.18 | 328.69% |
| 2021-04-15 | 7 | 44.84288 | 18.34486 | 26.49331 | 6.18 | 328.69% |
| 2021-04-15 | 6 | 45.08605 | 18.44434 | 26.63697 | 6.18 | 331.02% |
| 2021-04-15 | 7 | 45.08605 | 18.44434 | 26.63697 | 6.18 | 331.02% |
| 2020-05-13 | NA | 36.27000 | 18.40000 | 23.67000 | NA | NA% |
PRQR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 31 days, PRQR's average broker recommendation rating improved by 0.62.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRQR as an investment opportunity.
- PRQR has a higher upside potential (average analyst target price relative to current price) than 89.61% of all US stocks.
- The variance in analysts' estimates of PRQR is less than 17.33% of all US stocks.
- PRQR has a greater number of analysts covering the stock than 23.35% of all US stocks.
- The average analyst price target of PRQR is higher than 28.51% of all US stocks.
In the Pharmaceutical Products industry, KRON, AZYO and ETTX are the three stocks most similar to ProQR Therapeutics NV regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding PRQR using the data that counts. Try POWR Ratings for free.